The disposition kinetics, urinary excretion and dosage regimen of amikacin in cross-bred bovine calves
Tóm tắt
The disposition kinetics, urinary excretion and dosage regimen of amikacin after a single intravenous administration of 10 mg/kg was investigated in six cross-bred bovine calves. At 1 min, the concentration of amikacin in the plasma was 116.9±3.16 µg/ml and the minimum therapeutic concentration was maintained for 8 h. The elimination half-life and volume of distribution were 3.09±0.27 h and 0.4±0.03 L/kg, respectively. The total body clearance (ClB) and T/P ratio were 0.09±0.002 L/kg/h and 4.98±0.41, respectively. Approximately 50% of the total dose of amikacin was recovered in the urine within 24 h after administration. Amikacin in concentrations ranging from 5 to 150 µg/ml bound to plasma proteins to the extent of 6.32%±0.42%. A satisfactory intravenous dosage regimen of amikacin in bovine calves would be 13 mg/kg followed by 12 mg/kg at 12 h intervals.
Từ khóa
Tài liệu tham khảo
Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: second revision. Journal of Pharmaceutical Sciences, 60, 1689-1694
Baggot, J.D., Ling, G.V. and Chatfield, R.C., 1985. Clinical pharmacokinetics of amikacin in dogs. American Journal of Veterinary Research, 46, 1783-1796
Bauer, L.A. and Blouin, R.A., 1983. Influence of age on amikacin pharmacokinetics in patients without renal disease: comparison with gentamycin and tobramycin. European Journal of Clinical Pharmacology, 24, 639-642
Carli, S., Montesissa, C., Sanzogni, O., Madonna, M. and Said, F.A., 1990. Comparative pharmacokinetics of amikacin sulfate in calves and sheep. Research in Veterinary Science, 48, 231-234
Gibaldi, M. and Perrier, D., 1982. Methods of residuals. Pharmacokinetics, (Marcel Dekker, Inc., New York), 433-444
Huber, G.W., 1984. Aminoglycosides, macrolides, lincosamides, polymixins, chloramphenicol and other antibacterial agents. In: N.H. Booth and L.E. McDonald (eds), John's Veterinary Pharmacology and Therapeutics, (Kalyani Publishers, New Delhi), 748-771
Jernigan, A.D., Wilson, R.C. and Hatch, R.C., 1988. Pharmacokinetics of amikacin in cats. American Journal of Veterinary Research, 49, 355-358
Kunin, C.M., 1966. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clinical Pharmacology and Therapeutics, 7, 166-179
Leroy, A., Humbert, G., Oskenhendler, G. and Fillastre, J.P., 1978. Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function. Antibiotic Chemotherapy, 25, 163-180
Ling, G.V., Cozelman, G.M., Franti, C.E. and Ruby, A.L., 1981. Urine concentrations of gentamycin, tobramycin, amikacin and kanamycin after subcutaneous administration to healthy adult dogs. American Journal of Veterinary Research, 42, 1792-1794
Notori, R.E., 1973. Pharmacokinetics and molecular modification: Implications in drug design and evaluation. Journal of Pharmaceutical Sciences, 62, 865-881
Orsini, J.A., Soma, L.R., Rourke, J.E. and Park, M., 1985. Pharmacokinetics of amikacin in horse after intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 8, 194-201
Pechere, J.C. and Dugal, R., 1979. Clinical pharmacokinetics of aminoglycoside antibiotics. Clinical Pharmacokinetics, 4, 170-199
Uppal, R.P. and Verma, S.P., 1992. Urinary excretion of amikacin in sheep, goat and buffalo calves. Indian Veterinary Medical Journal, 16, 271-273
Witchel, M.G., Breuhaus, B.A. and Aucoin, D., 1992. Relation between pharmacokinetics of amikacin sulfate and sepsis score in clinically normal and hospitalized neonatal foals. Journal of American Veterinary Medical Association, 200, 1339-1343